CJC 1295(without DAC)5mg+IPA 5mg
Research Compound · 1 vial x 10mg
$58
| Pack size | 1 vial x 10mg |
| Contents | 5mg CJC-1295 (without DAC) + 5mg ipamorelin per vial |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
This vial combines CJC-1295 (without DAC) and Ipamorelin (5mg CJC-1295 (without DAC) + 5mg ipamorelin per vial).
CJC-1295 (without DAC)
CJC-1295 without DAC (Modified GRF 1-29) is a 29-amino-acid analog of growth hormone-releasing hormone (GHRH). Substitutions at positions 2, 8, 15, and 27 increase biological activity and slow metabolic clearance compared with native GRF (1-29). It binds the GHRH receptor to increase growth hormone production and release, and it has a shorter half-life than the DAC-conjugated version.
| Also known as | Modified GRF (1-29), tetrasubstituted GRF (1-29), GHRH (1-29)-NH2 |
| Compound type | Synthetic 29-amino-acid GHRH analog |
| Sequence | YaDAIFTQSYRKVLAQLSARKLLQDILSR-NH2 (a = D-Ala) |
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.9 g/mol |
Ipamorelin
Ipamorelin is a synthetic pentapeptide that acts as a selective agonist of the ghrelin / growth hormone secretagogue receptor (GHS-R). It increases plasma growth hormone in animals and humans and is used in research as a selective growth hormone secretagogue.
| Also known as | NNC 26-0161 |
| Compound type | Synthetic pentapeptide; ghrelin receptor (GHS-R) agonist |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular formula | C38H49N9O5 |
| Molecular weight | 711.9 g/mol |
| CAS number | 170851-70-4 |
Research areas
- GHRH receptor signaling
- Growth hormone release
- Peptide stability and clearance
- Growth hormone secretagogue receptor pharmacology
- Pituitary growth hormone release
- Pulsatile GH signaling
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.